Acute Market Reports pharmaceuticals report, Avastin (Ovarian Cancer) - Analysis and Forecasts to 2020 provides Avastin sales forecasts for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2012-2020).
The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.
Scope
Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Avastin including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Avastin including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecast for 2012-2020 for Avastin in the seven major markets
Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
Analysis and review of Avastin including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of Avastin including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecast for 2012-2020 for Avastin in the seven major markets
Click Here To Download Detail Report: http://www.acutemarketreports.com/request-free-sample/36917
Reasons to buy
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Ovarian Cancer 4
2.2 Ovarian Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Age 6
2.4.2 Inherited Gene Mutations 6
2.4.3 A Previous Cancer Diagnosis 6
2.4.4 Early Menstruation or Late menopause 7
2.4.5 Family History of Ovarian Cancer 7
2.5 GlobalData Report Guidance 7
2.1 Ovarian Cancer 4
2.2 Ovarian Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Age 6
2.4.2 Inherited Gene Mutations 6
2.4.3 A Previous Cancer Diagnosis 6
2.4.4 Early Menstruation or Late menopause 7
2.4.5 Family History of Ovarian Cancer 7
2.5 GlobalData Report Guidance 7
View all reports of this category @ http://www.acutemarketreports.com/category/ovarian-cancer-market
3 Ovarian Cancer: Market Characterization 8
3.1 Ovarian Cancer Market 8
3.2 Ovarian Cancer Market Forecasts and CAGR 8
3.3 Drivers for Ovarian Cancer Market 9
3.3.1 High Incidence 9
3.3.2 High Mortality Rate 10
3.3.3 Increased Use of Chemotherapy in Ovarian Cancer 11
3.3.4 Emergence of Targeted Drugs 11
3.3.5 Recurrence of Tumor 11
3.3.6 Low Initial Diagnosis Rate 11
3.1 Ovarian Cancer Market 8
3.2 Ovarian Cancer Market Forecasts and CAGR 8
3.3 Drivers for Ovarian Cancer Market 9
3.3.1 High Incidence 9
3.3.2 High Mortality Rate 10
3.3.3 Increased Use of Chemotherapy in Ovarian Cancer 11
3.3.4 Emergence of Targeted Drugs 11
3.3.5 Recurrence of Tumor 11
3.3.6 Low Initial Diagnosis Rate 11
4 Tumor-Node-Metastases (TNM) Classification of Ovarian Cancer 12
5 Avastin (bevacizumab) 15
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.3.1 First Line Trials 15
5.3.2 Second Line Trials 16
5.4 Approval History of Avastin 16
5.5 Factors Affecting Sales of Avastin 17
5.5.1 High Efficacy 17
5.5.2 Limited Treatment Options 17
5.5.3 Presence in Multiple Lines of Treatment 17
5.5.4 Wide Acceptance 17
5.6 Drug Evaluation 18
5.6.1 Drug Risk Benefit Score 18
5.6.2 Intensity of Competition 19
5.7 Sales Forecasts 19
5.7.1 Target Patient Pool of Avastin 19
5.7.2 Dosing 20
5.7.3 Market Penetration 20
5.7.4 Annual Cost of Therapy 21
5.7.5 Sales Forecasts of Avastin 22
5.1 Introduction 15
5.2 Mechanism of Action 15
5.3 Clinical Studies 15
5.3.1 First Line Trials 15
5.3.2 Second Line Trials 16
5.4 Approval History of Avastin 16
5.5 Factors Affecting Sales of Avastin 17
5.5.1 High Efficacy 17
5.5.2 Limited Treatment Options 17
5.5.3 Presence in Multiple Lines of Treatment 17
5.5.4 Wide Acceptance 17
5.6 Drug Evaluation 18
5.6.1 Drug Risk Benefit Score 18
5.6.2 Intensity of Competition 19
5.7 Sales Forecasts 19
5.7.1 Target Patient Pool of Avastin 19
5.7.2 Dosing 20
5.7.3 Market Penetration 20
5.7.4 Annual Cost of Therapy 21
5.7.5 Sales Forecasts of Avastin 22
6 Ovarian Cancer Market: Appendix 31
6.1 Market Definitions 31
6.2 List of Abberiviations 31
6.3 Research Methodology 31
6.3.1 Coverage 31
6.3.2 Secondary Research 32
6.3.3 Forecasting 32
6.3.4 Number of Patients Approved to take the Drug 32
6.3.5 Net Penetration of Drug 32
6.3.6 Net Annual Dosing 33
6.3.7 Annual Cost of Therapy 33
6.3.8 Primary Research 34
6.3.9 Expert Panels 34
6.4 Contact Us 34
6.5 Disclaimer 34
6.6 Sources 35
6.1 Market Definitions 31
6.2 List of Abberiviations 31
6.3 Research Methodology 31
6.3.1 Coverage 31
6.3.2 Secondary Research 32
6.3.3 Forecasting 32
6.3.4 Number of Patients Approved to take the Drug 32
6.3.5 Net Penetration of Drug 32
6.3.6 Net Annual Dosing 33
6.3.7 Annual Cost of Therapy 33
6.3.8 Primary Research 34
6.3.9 Expert Panels 34
6.4 Contact Us 34
6.5 Disclaimer 34
6.6 Sources 35
View Source: http://www.fpt2013.org/avastin-market/
About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Blog: http://mrramr.blogspot.com/
Website: Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Blog: http://mrramr.blogspot.com/
Website: Acute Market Reports
- Avastin Market
No comments:
Post a Comment